Clinical Report: Variations in Cascade Genetic Testing Practices in Families at Risk for Hereditary Cancer
Overview
This study investigates the rates and factors influencing cascade genetic testing among family members of probands with pathogenic variants.
Background
Germline genetic testing is crucial for managing hereditary cancer predispositions. Cascade testing involves testing family members after identifying a pathogenic variant in a proband.
Data Highlights
No numerical data provided in the source material.
Key Findings
Cascade testing is performed for only a minority of probands identified with pathogenic variants.
Demographic factors such as race, ethnicity, and socioeconomic status influence the likelihood of genetic testing uptake.
Probands from racial or ethnic minority groups and those with lower socioeconomic status utilize genetic testing at lower rates.
Some laboratories have implemented free testing policies to stimulate cascade testing rates, though their impact is not well studied.
Further examination of variables affecting cascade testing uptake among family members is needed.
Clinical Implications
Understanding the demographic and socioeconomic factors influencing cascade testing can help healthcare providers identify at-risk populations and improve testing rates. Implementing policies that facilitate access to genetic testing may enhance early cancer detection and management.
Conclusion
The study highlights the need to address disparities in cascade testing uptake.
